Challenges in the Therapy of Visceral Leishmaniasis in Brazil: A Public Health Perspective

Over 3,000 yearly cases of Visceral Leishmaniasis (VL) are reported in Brazil. Brazilian Public Health System provides universal free access to antileishmania therapeutic options: Meglumine Antimoniate, Amphotericin B deoxycholate, and Liposomal Amphotericin B. Even though Amphotericin formulations...

Descripción completa

Detalles Bibliográficos
Autores principales: de Melo, Edson Carvalho, Fortaleza, Carlos Magno Castelo Branco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870087/
https://www.ncbi.nlm.nih.gov/pubmed/24382969
http://dx.doi.org/10.1155/2013/319234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870087/
https://www.ncbi.nlm.nih.gov/pubmed/24382969
http://dx.doi.org/10.1155/2013/319234

Ejemplares similares